This meta-analysis uses 4 operational categories of brief psychotic episodes to look at the risk of recurrence of psychoses after a patient experiences a brief psychotic first episode.
This study presents preliminary evidence of dopamine sensitization in a socially excluded group of people with hearing impairment.
This randomized clinical trial shows that long-acting injectable risperidone resulted in better clinical outcomes than oral risperidone.
This case-control study examines whether the pattern of brain connectivity across striatal subregions is abnormal in unmedicated patients with schizophrenia and whether this abnormality relates to psychotic symptoms and extrastriatal dopaminergic transmission.
Kotov et al examine the associations between symptom course and long-term outcome to identify natural boundaries within psychotic disorders. Kendler provides an editorial.
This study assesses cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders.
This 12-week, double-blind, randomized clinical trial of naltrexone vs placebo in individuals with alcohol dependence does not support the hypothesis that the Asp40 allele moderates the response to naltrexone treatment.